Hitchhiking cancer vaccine makes progress in the clinic
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
Bendta Schroeder | Koch Institute •
mit
Feb. 15, 2024 • ~11 min
Feb. 15, 2024 • ~11 min
Nanoparticle-delivered RNA reduces neuroinflammation in lab tests
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
David Orenstein | Picower Institute •
mit
Dec. 15, 2023 • ~7 min
Dec. 15, 2023 • ~7 min
/
43